13-113233203-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001008895.4(CUL4A):c.539C>T(p.Thr180Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001008895.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CUL4A | NM_001008895.4 | c.539C>T | p.Thr180Ile | missense_variant | 6/20 | ENST00000375440.9 | NP_001008895.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CUL4A | ENST00000375440.9 | c.539C>T | p.Thr180Ile | missense_variant | 6/20 | 1 | NM_001008895.4 | ENSP00000364589.4 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000104 AC: 26AN: 251202Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135864
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461666Hom.: 0 Cov.: 31 AF XY: 0.0000371 AC XY: 27AN XY: 727132
GnomAD4 genome AF: 0.000355 AC: 54AN: 152324Hom.: 0 Cov.: 33 AF XY: 0.000416 AC XY: 31AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.539C>T (p.T180I) alteration is located in exon 6 (coding exon 6) of the CUL4A gene. This alteration results from a C to T substitution at nucleotide position 539, causing the threonine (T) at amino acid position 180 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at